Hereditary Angioedema Therapeutic Market Insights: US$ 14.19 Bn Forecast, 16.79% CAGR, Key Players Include BioCryst Pharmaceuticals, Ionis Pharmaceuticals, and More
Hereditary Angioedema Therapeutics Market Poised for Growth at 16.79% CAGR, Driven by Rising Awareness and Treatment Advancements
the global Hereditary Angioedema (HAE) therapeutics market is projected to reach US$ 14.19 billion by 2029, reflecting a robust compound annual growth rate (CAGR) of 16.79%. This press release highlights key findings from a new market report by Maximize Market...
0 Comments
0 Shares